Principal Financial Group Inc. decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 3.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,444 shares of the medical device company’s stock after selling 385 shares during […]
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 874,822 shares traded hands during mid-day trading, an increase of 167% from the previous session’s volume of 327,747 shares.The stock last traded at $35.47 and had previously closed at $42.00. Analysts Set New Price Targets Several research firms […]
StockNews.com upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a sell rating to a hold rating in a research note released on Thursday morning. ATRC has been the topic of a number of other research reports. BTIG Research upped their target price on shares of AtriCure from $56.00 to $68.00 in a research report […]
Vanguard Personalized Indexing Management LLC increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 6,307 shares of the medical device company’s stock after purchasing an additional 418 shares during the period. Vanguard Personalized […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price was up 2.2% during mid-day trading on Monday . The company traded as high as $37.30 and last traded at $36.33. Approximately 21,584 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 313,014 shares. The stock had previously closed […]